Infantile and late onset Pompe disease are different forms of a rare genetic condition that affects how the body processes glycogen. While both forms result from reduced acid alpha glucosidase enzyme activity, they differ in the age at which symptoms appear, the organs most affected, and the pattern of disease progression.
Pompe disease is a rare inherited metabolic disorder caused by changes in the GAA gene. These changes reduce or eliminate the activity of an enzyme called acid alpha glucosidase, which normally helps break down glycogen inside lysosomes. When glycogen accumulates, it can damage muscle cells and affect physical function. Pompe disease is generally classified into infantile onset and late onset forms based on the age of symptom development and the degree of enzyme activity.
Infantile onset Pompe disease usually develops during the first months of life. In the classic infantile form, acid alpha glucosidase activity is very low or absent, leading to significant glycogen accumulation in multiple tissues. The heart and skeletal muscles are often strongly affected.
Infants may experience muscle weakness, low muscle tone, feeding difficulties, poor weight gain, and delayed motor development. Enlargement and weakening of the heart can also occur in the classic form. Respiratory muscles may become affected, which can contribute to breathing difficulties.
Key characteristics associated with infantile onset Pompe disease may include:
There is also a nonclassic infantile form in which the heart may be less severely affected. The timing and severity of symptoms can vary between individuals, making medical assessment important when characteristic signs are present.
Late onset Pompe disease can develop during childhood, adolescence, or adulthood. People with this form generally have some remaining acid alpha glucosidase activity, and the condition often progresses more gradually than classic infantile onset Pompe disease.
The heart is usually less affected in late onset disease, while skeletal and respiratory muscles are commonly involved. Progressive weakness may begin in muscles around the hips, legs, shoulders, or trunk. Some individuals may notice difficulty climbing stairs, rising from a seated position, walking long distances, or lifting objects.
Important features of late onset Pompe disease may include:
Because late onset Pompe disease can resemble other neuromuscular conditions, diagnosis may sometimes take time. Enzyme testing and genetic testing can help healthcare professionals identify the condition and distinguish it from other causes of muscle weakness.
Although infantile and late onset Pompe disease share the same underlying genetic basis, they differ substantially in their typical age of onset, severity, and pattern of organ involvement. Infantile onset disease often progresses earlier and may involve significant heart and muscle complications, while late onset disease more commonly presents with gradually worsening skeletal and respiratory muscle weakness. Understanding these differences can help support disease awareness, appropriate testing, and informed discussions with qualified healthcare professionals.